739
Participants
Start Date
May 31, 2004
Primary Completion Date
September 30, 2005
Study Completion Date
September 30, 2005
VESIcare®
Oral
placebo
Oral
New York
Hewlett
Albany
East Syracuse
Endwell
Lewiston
Monroeville
Uniontown
Media
Philadelphia
Washington D.C.
Richmond
Morgantown
Winston-Salem
Concord
Hickory
Mt. Pleasant
Alpharetta
Marietta
Atlanta
Blue Ridge
Tallahassee
Gainesville
Pembroke Pines
Plantation
Boyton Beach
Clearwater
Clearwater
Cleveland
Cincinnati
Bloomfield Hills
Bismarck
Billings
Centralia
Chesterfield
St Louis
St Louis
Slidell
Escondido
Athens
Aurora
Denver
Boise
West Point
Ogden
Phoenix
Scottsdale
Albuquerque
Los Angeles
Mission Hills
Valley Village
Mission Viejo
Fresno
Salinas
Atherton
Carmichael
Eugene
Vancouver
Spokane
New London
Norwalk
Trumbull
Waterbury
Lawrenceville
South Bound Brook
Lead Sponsor
Astellas Pharma Inc
INDUSTRY